Founded in 2009 by Thomas Siebel, C3.ai's core purpose has always been to deliver AI solutions to enterprises. Its value ...

C3 Bullion, a pioneer in next-generation gold investment solutions, has launched its India operations, bringing its flagship ...

Pegcetacoplan inhibits C3 activation by binding to C3 and its activation fragment C3b, thereby reducing C3 glomerular fragment deposition in patients with C3G and primary IC-MPGN.

C3.ai, Inc. (AI) is one of the stocks most watched by Zacks.com visitors lately. So, it might be a good idea to review some ...

C3 glomerulopathy (C3G) and immune-complex membranoproliferative glomerulonephritis (IC-MPGN) are two diseases that have a ...

Finance Minister Ros Bates was informed of the Callide Power Station explosion just hours after the April 4 incident, new ...

A number of special basketball games in Springfield aimed to bring together at-risk youth and law enforcement in a fun and ...

Apellis Pharmaceuticals (NASDAQ:APLS) announced on Tuesday that the U.S. FDA approved its injectable medication Empaveli for ...

Note that some links may require registration or subscription. The HHS Office for Civil Rights launched an investigation into ...

Investing.com -- Apellis Pharmaceuticals, Inc. (NASDAQ: APLS) stock surged 12% after the U.S. Food and Drug Administration (FDA) approved EMPAVELI® (pegcetacoplan) as the first treatment for C3 ...

The European Commission has decided to change the volume limits for liquids allowed in airline carry-on luggage, lifting the ...

TheNewswire - Vancouver, British Columbia - Pampa Metals Corp. (“Pampa Metals”) (CSE:PM / FSE:FIR / OTCQB:PMMCF) is pleased to ...